Home/Filings/4/0001127602-19-018929
4//SEC Filing

Schomburger Jeffrey K 4

Accession 0001127602-19-018929

CIK 0000080424other

Filed

May 16, 8:00 PM ET

Accepted

May 17, 2:58 PM ET

Size

11.4 KB

Accession

0001127602-19-018929

Insider Transaction Report

Form 4
Period: 2019-05-16
Schomburger Jeffrey K
Global Sales Officer, CBD
Transactions
  • Exercise/Conversion

    Common Stock

    2019-05-16$63.05/sh+47,582$3,000,04562,452.198 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2019-05-1647,5820 total
    Exercise: $63.05From: 2014-02-28Exp: 2021-02-28Common Stock (47,582 underlying)
  • Sale

    Common Stock

    2019-05-16$107.00/sh47,582$5,091,27414,870.198 total
  • Award

    Restricted Stock Units

    2019-05-15+101.6171,662.884 total
    Common Stock (101.617 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    9,972.174
Footnotes (3)
  • [F1]Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock.
  • [F2]Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.
  • [F3]These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.

Issuer

PROCTER & GAMBLE Co

CIK 0000080424

Entity typeother

Related Parties

1
  • filerCIK 0001630117

Filing Metadata

Form type
4
Filed
May 16, 8:00 PM ET
Accepted
May 17, 2:58 PM ET
Size
11.4 KB